Viewing Study NCT00164892


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 12:15 PM
Study NCT ID: NCT00164892
Status: UNKNOWN
Last Update Posted: 2005-11-17
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
Sponsor: Chinese University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module